Product NDC: | 0049-0114 |
Proprietary Name: | ERAXIS |
Non Proprietary Name: | ANIDULAFUNGIN |
Active Ingredient(s): | 50 mg/15mL & nbsp; ANIDULAFUNGIN |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0049-0114 |
Labeler Name: | Roerig |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021632 |
Marketing Category: | NDA |
Start Marketing Date: | 20060217 |
Package NDC: | 0049-0114-28 |
Package Description: | 15 mL in 1 VIAL, SINGLE-USE (0049-0114-28) |
NDC Code | 0049-0114-28 |
Proprietary Name | ERAXIS |
Package Description | 15 mL in 1 VIAL, SINGLE-USE (0049-0114-28) |
Product NDC | 0049-0114 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ANIDULAFUNGIN |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20060217 |
Marketing Category Name | NDA |
Labeler Name | Roerig |
Substance Name | ANIDULAFUNGIN |
Strength Number | 50 |
Strength Unit | mg/15mL |
Pharmaceutical Classes | Echinocandin Antifungal [EPC],Lipopeptides [Chemical/Ingredient] |